Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

Reporting Tools in Cybersecurity and Penetration Testing

Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...

Daily Bulletin - avatar Daily Bulletin

High-Quality Stainless Steel Suppliers in Melbourne | Stainless Trading Melbourne

Stainless steel plays a crucial role in modern industries due to its exceptional durability, outstanding corrosion resistance, and aesthetically pleasing appearance. It is used in many applications...

Daily Bulletin - avatar Daily Bulletin

What Businesses Need to Know About Intellectual Property Law

Whether you're launching a startup or growing an established brand, understanding intellectual property law is essential. An intellectual property lawyer in Melbourne can guide you through registrat...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals